RECURRENCE RATE IN PATIENTS WITH SURGICALLY MANAGED STAGE I ENDOMETRIAL CARCINOMA.

被引：0
|
作者：
Kuljarusnont, S. [1 ]
Jaishuen, A. [1 ]
机构：
[1] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0482
引用
收藏
页码：1411 / 1411
页数：1
相关论文
共 50 条
  • [1] Long-term clinical outcome and pattern of recurrence of 657 surgically staged patients with stage I/II endometrial carcinoma. A single-institution experience
    Elshaikh, M.
    Ibrahim, D.
    Cote, M.
    Rouba, A.
    Schultz, D.
    Kim, W.
    Munkarah, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S68 - S68
  • [2] High-dose-rate brachytherapy (HDRB) as an alternative to surgery in selected patients with stage I endometrial carcinoma.
    Niazi, TM
    Souhami, L
    Stanimir, GW
    Portelance, L
    Bahoric, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S33 - S33
  • [3] Recurrence factors of stage I ovarian clear cell carcinoma.
    Takei, Yuji
    Fujiwara, Hiroyuki
    Machida, Shizuo
    Taneichi, Akiyo
    Takahashi, Suzuyo
    Takahashi, Yoshifumi
    Saga, Yasushi
    Suzuki, Mitsuaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Ovarian preservation in young patients with early stage endometrial carcinoma.
    Lv, Lin
    Peng, Zhilan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] REGIONAL RECURRENCE RATES OF STAGE I ENDOMETRIAL CARCINOMA PATIENTS TREATED WITH ADJUVANT BRACHYTHERAPY
    Alanyali, S.
    Sert, F.
    Gocen, F.
    Temel, O.
    Ozsaran, Z.
    Yildirim, N.
    Solmaz, U.
    Gokcu, M.
    Akman, L.
    Terek, C.
    Ozsaran, A.
    Sanci, M.
    Yildiz, H. I.
    Ozkok, S.
    Aras, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1020 - 1020
  • [6] REGIONAL RECURRENCE RATES OF STAGE I ENDOMETRIAL CARCINOMA PATIENTS TREATED WITH ADJUVANT BRACHYTHERAPY
    Alanyali, S.
    Sert, F.
    Gocen, F.
    Temel, O.
    Ozsaran, Z.
    Yildirim, N.
    Solmaz, U.
    Gokcu, M.
    Akman, L.
    Terek, C.
    Ozsaran, A.
    Sanci, M.
    Yildiz, H. I.
    Ozkok, S.
    Aras, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 172 - 172
  • [7] Baseline risk of recurrence in stage I-II endometrial carcinoma
    Sasada, Shinsuke
    Yunokawa, Mayu
    Takehara, Yae
    Ishikawa, Mitsuya
    Ikeda, Shunichi
    Kato, Tomoyasu
    Tamura, Kenji
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (01)
  • [8] High-dose rate brachytherapy for selected patients with stage I endometrial carcinoma
    Niazi, MT
    Souhami, L
    Stanimir, GW
    Portelance, L
    Bahoric, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S239 - S240
  • [9] Benefit of adjuvant radiotherapy in surgically staged stage I-II endometrial carcinoma
    Köse, MF
    Garipagaoglu, M
    Kayikçioglu, F
    Yalvaç, S
    Adli, M
    Koçak, Z
    Boran, N
    Haberal, A
    Cakmak, A
    [J]. TUMORI, 2000, 86 (01) : 59 - 63
  • [10] RESULTS OF TREATMENT IN PATIENTS WITH STAGE I ENDOMETRIAL CARCINOMA
    Rath, G. K.
    Sharma, D.
    Milind, K.
    Julka, P.
    Bahl, A.
    Haresh, K.
    Kumar, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S247 - S247
12345